Effects of Cl Esterase Inhibitor on IL-2 Toxicity
Author Information
Author(s): A.C. Ogilvie, J.W. Baars, A.J.M. Eerenberg, C.E. Hack, H.M. Pinedo, L.G. Thijs, J. Wagstaff
Primary Institution: Free University Hospital, Amsterdam, The Netherlands
Hypothesis
Can Cl esterase inhibitor administration reduce the toxicity associated with high-dose interleukin 2 treatment?
Conclusion
Cl esterase inhibitor administration during high-dose IL-2 treatment is safe and may help reduce IL-2-induced toxicity.
Supporting Evidence
- IL-2-induced hypotension was equivalent in both treatment groups.
- Complement activation was less after IL-2 + C1-INH compared to standard IL-2.
- No side effects were observed from C1-INH administration.
- Weight gain was significantly greater during the experimental and historical-control courses than during the self-control course.
- Total C1-INH levels increased significantly during the experimental course.
Takeaway
This study looked at whether a medicine called Cl esterase inhibitor could make another medicine, interleukin 2, less harmful. It found that using Cl esterase inhibitor was safe and might help reduce side effects.
Methodology
Six patients received high-dose IL-2 with Cl esterase inhibitor, and results were compared to historical controls and self-control courses.
Potential Biases
Potential biases due to the open-label design and small number of participants.
Limitations
Small sample size and lack of a double-blind design.
Participant Demographics
Patients included both males and females with renal cell carcinoma and melanoma, aged 35 to 57 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website